Bank Vontobel AG Share Price

RMAS7V

CH1315861554

Market Closed - Swiss Exchange 08:50:00 07/06/2024 pm IST
97.7 ^USD	+0.31%

Current month	-1.41%
1 month	-1.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Geron shares surge after U.S. FDA approves blood disorder drug	07/06	RE
I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	05/06	MT
Bristol Myers Squibb Announces Opdivo Plus Yervoy Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma	05/06	AQ
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	05/06	CI

More news

Quotes 5-day view

Date	Price	Change
07/24/07	97.7	+0.31%
06/24/06	97.4	-2.99%
03/24/03	100.4	+1.31%
31/24/31	99.1	+1.43%
30/24/30	97.7	+0.21%

Delayed Quote Swiss Exchange

Last update June 07, 2024 at 08:50 pm IST

More quotes

Static data

Product type	Reverse Convertibles
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Vontobel
	RMAS7V
ISIN	CH1315861554
Date issued	01/03/2024
Strike	50.89 $
Maturity	02/09/2025 (451 Days)
Parity	0.05 : 1
Emission price	100 $
Emission volume	N/A
Settlement	both
Currency	USD

Technical Indicators

Highest since issue	101 $
Lowest since issue	97 $
Spread	10 $
Spread %	1.01%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.48 USD

Average target price

53.19 USD

Spread / Average Target

+28.24%

Consensus